Literature DB >> 25778820

Apoptosis induced by sonodynamic therapy in human osteosarcoma cells in vitro.

Xing Liu1, Wei Li1, Shuo Geng1, Qing-Gang Meng2, Zheng-Gang Bi1.   

Abstract

The aim of the present study was to investigate the potential effect of hematoporphyrin monomethyl ether-sonodynamic therapy (HMME-SDT) on MG-63 osteosarcoma cells. The HMME concentration was kept constant at 20 µg/ml and the MG-63 osteosarcoma cell line was exposed to ultrasound with an intensity of 1.0 W/cm2 for 30 sec. Cell cytotoxicity was quantified using an MTT assay 6 h after HMME-SDT. The intracellular localization of HMME was imaged using inverted confocal laser scanning microscopy. Apoptosis was investigated using flow cytometry with Annexin V-fluorescein isothiocyanate and propidium iodine staining. The cytotoxicity of HMME-mediated sonodynamic action on MG-63 cells was significantly higher than that of other treatments, including ultrasound alone, HMME alone and sham treatment. Flow cytometry demonstrated that HMME‑SDT action markedly enhanced the apoptotic rate of MG-63 cells. The mechanisms of apoptosis were analyzed by measuring the protein expression of poly ADP-ribose polymerase (PARP), cleaved PARP, procaspase-3, cleaved caspase-3 and cleaved caspase-9. The data demonstrated that HMME-SDT action markedly induced the apoptosis of MG-63 cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25778820     DOI: 10.3892/mmr.2015.3479

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  2 in total

1.  Low-Intensity Ultrasound Combined with Hematoporphyrin Monomethyl Ether in the Treatment of Experimental Periodontitis in Rats.

Authors:  Deshu Zhuang; Zongshan Ji; Liangjia Bi; Xiaochun Wang; Qi Zhou; Wenwu Cao
Journal:  Biomed Res Int       Date:  2016-11-16       Impact factor: 3.411

Review 2.  The crosstalk between sonodynamic therapy and autophagy in cancer.

Authors:  Yujie Zhang; Yuanru Zhao; Yuanyuan Zhang; Qingguang Liu; Mingzhen Zhang; Kangsheng Tu
Journal:  Front Pharmacol       Date:  2022-08-15       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.